140 related articles for article (PubMed ID: 6679050)
1. Phenylpropanolamine-associated hypertension after the use of "over-the-counter" appetite-suppressant products.
McEwen J
Med J Aust; 1983 Jul; 2(2):71-3. PubMed ID: 6679050
[TBL] [Abstract][Full Text] [Related]
2. Hypertensive crisis resulting from an MAO inhibitor and an over-the-counter appetite suppressant.
Smookler S; Bermudez AJ
Ann Emerg Med; 1982 Sep; 11(9):482-4U. PubMed ID: 7114595
[TBL] [Abstract][Full Text] [Related]
3. Cerebral infarction with a single oral dose of phenylpropanolamine.
Edwards M; Russo L; Harwood-Nuss A
Am J Emerg Med; 1987 Mar; 5(2):163-4. PubMed ID: 3828020
[TBL] [Abstract][Full Text] [Related]
4. Combining nonprescription medications.
Shuster J
Nursing; 1998 Jun; 28(6):77. PubMed ID: 9668801
[No Abstract] [Full Text] [Related]
5. Hypertensive responses induced by phenylpropanolamine in anorectic and decongestant preparations.
Horowitz JD; Lang WJ; Howes LG; Fennessy MR; Christophidis N; Rand MJ; Louis WJ
Lancet; 1980 Jan; 1(8159):60-1. PubMed ID: 6153233
[TBL] [Abstract][Full Text] [Related]
6. PPA: an innocent over-the-counter drug?
Ludwikowski KL
Pediatr Nurs; 1984; 10(6):387-90. PubMed ID: 6569428
[No Abstract] [Full Text] [Related]
7. Phenylpropanolamine-induced hypertensive seizures.
Howrie DL; Wolfson JH
J Pediatr; 1983 Jan; 102(1):143-5. PubMed ID: 6848713
[No Abstract] [Full Text] [Related]
8. Nonprescription appetite suppressants.
Drew R
N C Med J; 1983 Sep; 44(9):573-4. PubMed ID: 6579375
[No Abstract] [Full Text] [Related]
9. Over-the-counter phenylpropanolamine: a possible cause of central retinal vein occlusion.
Gilmer G; Swartz M; Teske M; Crandall AS
Arch Ophthalmol; 1986 May; 104(5):642. PubMed ID: 3707408
[No Abstract] [Full Text] [Related]
10. Neurological and cardiac events on phenylpropanolamine.
Prescrire Int; 1999 Dec; 8(44):181. PubMed ID: 11503819
[TBL] [Abstract][Full Text] [Related]
11. Severe hypertension after ingestion of an appetite suppressant (phenylpropanolamine) with indomethacin.
Lee KY; Beilin LJ; Vandongen R
Lancet; 1979 May; 1(8126):1110-1. PubMed ID: 86834
[TBL] [Abstract][Full Text] [Related]
12. Phenylpropanolamine and blood pressure.
Lasagna L
JAMA; 1985 May; 253(17):2491-3. PubMed ID: 3981773
[No Abstract] [Full Text] [Related]
13. Hazards of the appetite suppressant phenylpropanolamine.
Bennett WM
Lancet; 1979 Jul; 2(8132):42-3. PubMed ID: 87921
[No Abstract] [Full Text] [Related]
14. FDA issues public health advisory on phenylpropanolamine in drug products.
Meadows M
FDA Consum; 2001; 35(1):9. PubMed ID: 11930934
[No Abstract] [Full Text] [Related]
15. Amphetamine-like reactions to phenylpropanolamine.
Dietz AJ
JAMA; 1981 Feb; 245(6):601-2. PubMed ID: 7452888
[TBL] [Abstract][Full Text] [Related]
16. Phenylpropanolamine and stroke: the study, the FDA ruling, the implications.
Mersfelder TL
Cleve Clin J Med; 2001 Mar; 68(3):208-9, 213-9, 223. PubMed ID: 11263849
[TBL] [Abstract][Full Text] [Related]
17. Phenylpropanolamine and hypertension.
Teh AY
Med J Aust; 1979 Oct; 2(8):425-6. PubMed ID: 318482
[No Abstract] [Full Text] [Related]
18. Phenylpropanolamine and hemorrhagic stroke.
Ernst ME; Hartz A
N Engl J Med; 2001 Apr; 344(14):1094; author reply 1095. PubMed ID: 11291667
[No Abstract] [Full Text] [Related]
19. [Cerebral hemorrhage associated with the use of phenylpropanolamine. Clinical cases].
Tapia J
Rev Med Chil; 1996 Dec; 124(12):1499-503. PubMed ID: 9334487
[TBL] [Abstract][Full Text] [Related]
20. Rhabdomyolysis after ingestion of an appetite suppressant.
Rumpf KW; Kaiser HF; Horstkotte H; Bahlmann J
JAMA; 1983 Oct; 250(16):2112. PubMed ID: 6620516
[No Abstract] [Full Text] [Related]
[Next] [New Search]
